1. Khan, Abdul Jamil, Man, Shad, Abbas, Manzar, Liu, Shihao, Zhang, Feng. 2024. FBXO8 is a novel prognostic biomarker in different molecular subtypes of breast cancer and suppresses breast cancer progression by targeting c-MYC. In Biochimica et biophysica acta. General subjects, 1868, 130577. doi:10.1016/j.bbagen.2024.130577. https://pubmed.ncbi.nlm.nih.gov/38301858/
2. Calcia, Alessandro, Gai, Giorgia, Di Gregorio, Eleonora, Grosso, Enrico, Brusco, Alfredo. 2013. Bilaterally cleft lip and bilateral thumb polydactyly with triphalangeal component in a patient with two de novo deletions of HSA 4q32 and 4q34 involving PDGFC, GRIA2, and FBXO8 genes. In American journal of medical genetics. Part A, 161A, 2656-62. doi:10.1002/ajmg.a.36146. https://pubmed.ncbi.nlm.nih.gov/24038848/
3. Luo, Zhouan, Wu, Xiaoping, Xie, Juanxia, Dou, Shangwen, Chen, Songning. 2024. Diagnostic and prognostic potential of FBXO8 expression in kidney renal clear cell carcinoma and its regulation of renal adenocarcinoma cells. In Cancer genetics, 290-291, 6-15. doi:10.1016/j.cancergen.2024.11.004. https://pubmed.ncbi.nlm.nih.gov/39647237/
4. Zhu, Xiaohui, Wang, Feifei, Wu, Xuehui, Liao, Wenting, Liang, Li. 2020. FBX8 promotes metastatic dormancy of colorectal cancer in liver. In Cell death & disease, 11, 622. doi:10.1038/s41419-020-02870-7. https://pubmed.ncbi.nlm.nih.gov/32796813/
5. Cho, Hyun Jung, Oh, Yun Jeong, Kwon, Junhye, Kim, Kyung-Soo, Kim, Hongtae. 2010. c-Myc stimulates cell invasion by inhibiting FBX8 function. In Molecules and cells, 30, 355-62. doi:10.1007/s10059-010-0134-8. https://pubmed.ncbi.nlm.nih.gov/20848231/